Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-20-037451

Director sold 2,000 shares at an average $43.00 ($85,997)

  • Director acquired 2,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
HERSHBERG ROBERT Director 2020-06-15 Option exercise +2,000 $0.45 $900 2,000 D
HERSHBERG ROBERT Director 2020-06-15 Sale −1,016 $42.59 $43,271 984 D
HERSHBERG ROBERT Director 2020-06-15 Sale −984 $43.42 $42,725 0 D
Derivatives
HERSHBERG ROBERT Director 2020-06-15 Option exercise · Stock Option (Right to Buy) −2,000 71,000 D
Open-market sales · 2,000 sh · avg $43.00 · $85,997
Loading xslF345X03/doc4.xml…